Area of research
Genetics · Epidemiology
Research interest
Research interests include Glioma Diagnosis and Treatment, Meningioma and schwannoma management, Neurofibromatosis and Schwannoma Cases, and Brain Metastases and Treatment.
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13, 466
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
The prognostic role of the immunohistochemical expression of S100 in meningiomas
Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas
The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort
Increased proliferation is associated with CNS invasion in meningiomas
A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized Trials
Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
Mib1 Expression Is Increased in Meningiomas with Histopathological Evidence of Cns Invasion
H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
CNS Invasion in Meningioma—How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence
FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma
High frequency of H3 K27M mutations in adult midline gliomas
Integrative assessment of brain and bone invasion in meningioma patients
Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
Actively personalized vaccination trial for newly diagnosed glioblastoma
High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma
Low FoxG1 and high Olig‐2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)‐mutant gliomas
ATRX immunostaining predicts IDH and H3F3A status in gliomas
Frequency of BRAF V600E mutations in 969 central nervous system neoplasms